MAIN CONTENT
A Brazilian squeeze reverberates on Wall Street
Corteva’s revised guidance followed a much weaker-than-anticipated crop-protection market in Brazil, a major agricultural economy and important destination for herbicides, fungicides and other farm inputs. Reuters reported that the shares dropped 22.8% to $9.36 during Thursday trading and were heading for a potentially record percentage decline. That snapshot captures investor anxiety rather than the eventual closing price, which may differ.
The company identified a cluster of mutually reinforcing pressures: farmers had less ready cash, loans were expensive, distributors carried substantial inventory and buyers placed orders closer to the moment of use. Competitive discounting further weakened prices for older active ingredients. Such conditions can turn a normal seasonal slowdown into a pronounced earnings shock when producers postpone purchases across the distribution chain.
Regional figures expose the imbalance
Corteva reported third-quarter pro forma net sales of approximately $1.59 billion, 9% below the prior-year level. Its adjusted pro forma operating EBITDA fell 17% to $222 million, while its pro forma loss from continuing operations after tax reached $54 million.
















